Guardant Health
GH
#1787
Rank
โ‚น1.046 T
Marketcap
โ‚น7,980
Share price
-3.96%
Change (1 day)
106.24%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚น189.90 Billion

According to Guardant Health 's latest financial reports the company's total assets are โ‚น189.90 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚น180.76 B41.84%
2024-12-31โ‚น127.44 B-14.3%
2023-12-31โ‚น148.71 B11.63%
2022-12-31โ‚น133.22 B-18.81%
2021-12-31โ‚น164.08 B-1.24%
2020-12-31โ‚น166.14 B142.05%
2019-12-31โ‚น68.63 B67.12%
2018-12-31โ‚น41.07 B87.57%
2017-12-31โ‚น21.89 B176.44%
2016-12-31โ‚น7.92 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
โ‚น316.87 B 66.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚น226.18 B 19.10%๐Ÿ‡บ๐Ÿ‡ธ USA